SpyGlass Pharma Appoints Shannon Treviño as General Counsel
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
SpyGlass Pharma to Participate in Upcoming Investor Conferences
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Analyzing Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP)
SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update
Comparing Spyglass Pharma (NASDAQ:SGP) & Nanovibronix (NASDAQ:FEED)
Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP) Financial Comparison
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit
3 Macro Charts That Matter Now: U.S. Dollar, Gold, S&P 500
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More
Reddit, KKR, and 2 Biotech IPOs Seeing the Love From Insiders
Market Today: Jobs Beat Sways Stocks; MCD, WBD in Focus
First Look: Jobs Data Looms; WBD-NFLX Fight, Moderna Setback
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years
SpyGlass Pharma Announces Pricing of Initial Public Offering
U.S. IPO Weekly Recap: Trio Of Sizable Listings Underwhelm To Close Out January